Novartis Whistleblower Case Dismissed Again
A US District Judge has dismissed a whistleblower case against Novartis yet again. The case, brought by Steven Camburn, a former Novartis sales rep who alleged that the company was giving physicians kickbacks to encourage them to prescribe Gilenya, a drug for multiple sclerosis. Judge Kimba Wood ruled that Camburn has not provided enough evidence to support his claims
US Court Rejects Novartis’s Appeal in Whistleblower Case
New Jersey’s Superior Court, Appellate Division, has rejected Novartis’s appeal of a 2019 verdict in a case against a former executive turned whistleblower. Min Amy Guo, then executive director of the company’s health economics and outcomes research team, was fired in 2013 after expressing concerns that a cancer drug study would violate laws preventing kickbacks. She filed suit the following year and five years later a New Jersey court ruled Novartis was guilty of retaliation and must pay Guo $1.8 million in damages.
